Algert Global’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Sell
1,610,747
-184,133
-10% -$1.3M 0.16% 177
2026
Q1
$11.6M Buy
1,794,880
+569,846
+47% +$4.41M 0.17% 166
2025
Q4
$10M Buy
1,225,034
+202,435
+20% +$1.83M 0.16% 193
2025
Q3
$9.07M Buy
1,022,599
+557,898
+120% +$3.53M 0.15% 213
2025
Q2
$2.43M Buy
464,701
+343,956
+285% +$1.75M 0.05% 572
2025
Q1
$654K Buy
120,745
+77,650
+180% +$366K 0.02% 850
2024
Q4
$197K Buy
43,095
+10,806
+33% +$55.3K ﹤0.01% 1079
2024
Q3
$168K Buy
+32,289
New +$146K ﹤0.01% 1084
2022
Q4
Sell
-82,183
Closed -$123K 1133
2022
Q3
$123K Buy
82,183
+9,713
+13% +$20K 0.01% 1089
2022
Q2
$164K Sell
72,470
-2,930
-4% -$8.49K 0.01% 1051
2022
Q1
$257K Buy
+75,400
New +$409K 0.02% 983

Other funds holding AVAH

Algert Global's AVAH Position: Q2 2026 in Review

Algert Global reduced its Aveanna Healthcare (AVAH) stake by 10% in Q2 2026, selling an estimated $1.3M and leaving 1,610,747 shares worth $13.8M. The position accounts for 0.16% of the portfolio, ranked #177.

Algert Global first reported a position in AVAH in Q1 2022 and has held it in 11 quarters since. 216 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Algert Global held 1,610,747 shares of Aveanna Healthcare worth $13.8M as of Q2 2026.
  • Algert Global sold 184,133 Aveanna Healthcare shares in Q2 2026, an estimated $1.3M.
  • Aveanna Healthcare made up 0.16% of Algert Global's portfolio in Q2 2026, its #177 holding.
  • Algert Global first reported a position in Aveanna Healthcare in Q1 2022 and has held it in 11 quarters since.
  • 216 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.